Dr Batra’s Healthcare has announced the launch of HairGain, a new non-surgical hair regrowth treatment that uses exosome-based regenerative technology. According to the company, HairGain is powered by 50 billion exosomes and is designed to support natural hair regrowth in people experiencing different types of hair loss.
The treatment has been developed for men and women dealing with hereditary hair loss, post-pregnancy hair fall, menopause-related hair thinning, stress-induced hair loss, and early-stage hair thinning. It aims to stimulate dormant hair follicles, improve scalp health, and promote healthier hair growth.
HairGain is based on Dr Batra’s proprietary TriXo Complex, which combines exosomes with ingredients such as PDRN (Polydeoxyribonucleotide), collagen, caffeine, growth factors, polypeptides, and copper tripeptides. The company says this combination helps support scalp regeneration, strengthen hair roots, improve scalp circulation, and enhance hair density over time.
Dr Akshay Batra, Vice-Chairman and Managing Director of Dr Batra’s Healthcare, said regenerative therapies are changing the approach to hair restoration by offering minimally invasive options that work with the body’s natural healing processes. He added that standardized exosome therapy may provide a more consistent regenerative stimulus compared to platelet-rich plasma (PRP) treatments.
According to the company, patients may begin to see visible improvements in around 75 days, depending on their condition and treatment plan, under clinical supervision.
Dr Batra’s Healthcare, which operates more than 200 clinics across around 130 cities in 10 countries, said the launch reflects its continued focus on bringing advanced regenerative therapies to patients seeking non-surgical hair restoration solutions.
Note: The treatment claims and expected outcomes are based on information provided by Dr Batra’s Healthcare. Independent clinical validation and individual results may vary.